RESPONSE BIOMEDICAL CORP·4

Mar 21, 3:07 PM ET

PURVIN JEFFREY L 4

4 · RESPONSE BIOMEDICAL CORP · Filed Mar 21, 2013

Insider Transaction Report

Form 4
Period: 2013-03-19
PURVIN JEFFREY L
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2013-03-19$3.58/sh+4,300$15,3864,300 total
Holdings
  • Common Stock

    (indirect: By Trust)
    250,000
Footnotes (2)
  • [F1]The purchase price reported in column 4 of Table I represents the weighted average price of the shares purchased ranging from $3.52 to $3.5965 per share.
  • [F2]Shares held directly by the Purvin Family Trust, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT